in the current report , the baseline period , during which gentamicin was the first-line aminoglycoside , accounting for 61 percent of overall aminoglycoside use , is compared with the period from january 1982 to september 1985 , during which the first-line aminoglycoside was amikacin , accounting for 85 percent of overall use .
C0017436
gentamicin
C0002556
aminoglycoside